CLBS - Caladrius Biosciences - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $7.79. This is a potential upside of $7.79 (0%) from yesterday's end of day stock price of $0.

Caladrius Biosciences's activity chart (see below) currently has 3 price targets and 12 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 27-Apr-2022.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

3 years 13 days ago
(27-Apr-2022)

0/2 (0%)

$13.85 (297.85%)

Buy

3 years 1 months 17 days ago
(23-Mar-2022)

0/1 (0%)

$9.52 (173.72%)

Show more analysts

What is CLBS (Caladrius Biosciences) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CLBS (Caladrius Biosciences) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the current lower performing score on CLBS (Caladrius Biosciences) with a proven track record?

JASON KOLBERT

Which analyst has the most public recommendations on CLBS (Caladrius Biosciences)?

Joseph Pantginis has 30 price targets and 23 ratings on CLBS

Which analyst is the currently most bullish on CLBS (Caladrius Biosciences)?

Jason Kolbert with highest potential upside - $0

Which analyst is the currently most reserved on CLBS (Caladrius Biosciences)?

Joseph Pantginis with lowest potential downside - -$0